Wes Streeting’s row with pharma firms grows as talks end on NHS drug pricing
Drugmakers reject health secretary’s latest offer, meaning ‘unsustainable’ rebate scheme will stay in placeBusiness live – latest updatesA row between Wes Streeting and pharmaceutical companies has intensified after drugmakers rejected the health secre…